1. Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Christophe Moreno, Sebastian Mueller, Gyongyi Szabo 
Journal of Hepatology 
Volume 70, Issue 2, Pages (February 2019)
DOI: /j.jhep
Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1 Factors influencing liver stiffness measurement.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Practical algorithm in patient with excessive alcohol consumption. AST, aspartate aminotransferase; HCC, hepatocellular carcinoma.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Influence of AST elevation on liver stiffness measurement in ALD patients. ALD, alcohol-related liver disease; AST, aspartate aminotransferase.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

5. Fig. 4
MicroRNAs as emerging biomarkers in ALD. In ALD, miR-155 expression is increased in the liver in hepatocytes and particularly in Kupffer cells and macrophages. Hepatocyte expression of miR-122 is reduced in ALD in mice. These changes in the liver occur while circulating levels of several miRNAs increase including miR-122, miR-155, miR-192 and miR-30a. Most of these miRNAs a found in the circulation packaged into exosomes and/or extracellular vesicles. ALD, alcohol-related liver disease; miRNAs, small non-coding RNAs.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2018 European Association for the Study of the Liver Terms and Conditions